AMI Asset Management’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
RI
DC
TCM
AMI Asset Management's CGON Position: Q2 2026 in Review
AMI Asset Management reduced its CG Oncology (CGON) stake by 3.6% in Q2 2026, selling an estimated $47.8K and leaving 19,398 shares worth $1.38M. The position accounts for 0.08% of the portfolio, ranked #40.
AMI Asset Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.78M in Q3 2025. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.
- AMI Asset Management held 19,398 shares of CG Oncology worth $1.38M as of Q2 2026.
- AMI Asset Management sold 731 CG Oncology shares in Q2 2026, an estimated $47.8K.
- CG Oncology made up 0.08% of AMI Asset Management's portfolio in Q2 2026, its #40 holding.
- AMI Asset Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
- AMI Asset Management's CG Oncology position peaked at $1.78M in Q3 2025.
- 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.
Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.